Published On: Apr 29, 2020

The All India Institute Of Medical Sciences is planning to conduct a clinical trial of the convalescent plasma therapy in the treatment of COVID-19 and modalities of taking approvals from the Drug Controller General of India are being worked out. AIIMS Director Dr Randeep Guleria said the mode of treatment in COVID-19 is still at an "experimental stage" and there is a need for good and well conducted research trials before its benefit and this mode of therapy can be recommended for routine use in coronavirus patients.  

Related Videos

Entertainment Articles